Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction

Published:September 25, 2013DOI:



      The disparity between ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) remains controversial. We compared clinical outcomes and prognostic factors between STEMI and NSTEMI using large-scale registry data.


      We recruited 28,421 patients with STEMI (n = 16,607) and NSTEMI (n = 11,814) between November 2005 and April 2010 from a nationwide registry in Korea. We performed landmark analysis of cardiac death, recurrent acute myocardial infarction (re-AMI), revascularization, and major adverse cardiac events (MACE) at 30 days (early term) and 1 year (late term) after admission.


      Patients with NSTEMI had a greater number of co-morbidities than STEMI patients. Early term MACE (6.9% vs. 4.5%, p < 0.001) and cardiac death (6.1% vs. 3.7%, p < 0.001) were higher in STEMI patients. However, late-term MACE (8.0% vs. 9.1%, p = 0.007), cardiac death (1.9% vs. 2.6%, p = 0.001), and re-AMI (0.6% vs. 1.3%, p < 0.001) were lower in the STEMI group. The independent predictors of cardiac death were old age, renal dysfunction, LV dysfunction, Killip class, post-thrombolysis in myocardial infarction (TIMI) flow, and major bleeding in both groups. Female gender, previous ischemic heart disease, diabetes, current smoking, multivessel disease, and body mass index were MI type- or time-dependent predictors.


      The STEMI group displayed poor early term clinical outcome, whereas the NSTEMI group displayed poor late-term clinical outcome. The STEMI and NSTEMI groups had different predictor profiles for cardiac death, suggesting that different strategies are required for improving the late-term outcome of STEMI and NSTEMI patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Simoons M.L.
        • Chaitman B.R.
        • White H.D.
        Third universal definition of myocardial infarction.
        Circulation. 2007; 116: 2634-2653
        • Rogers W.J.
        • Frederick P.D.
        • Stoehr E.
        • et al.
        Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
        Am Heart J. 2008; 156: 1026-1034
        • O'Gara P.T.
        • Kushner F.G.
        • Ascheim D.D.
        • et al.
        ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive Summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2013; 2012
        • Wright R.S.
        • Anderson J.L.
        • Adams C.D.
        • et al.
        2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2011; 57: 1920-1959
        • Libby P.
        Current concepts of the pathogenesis of the acute coronary syndromes.
        Circulation. 2001; 104: 365-372
        • Antman E.M.
        • Anbe D.T.
        • Armstrong P.W.
        • et al.
        ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the management of patients with acute myocardial infarction).
        Circulation. 2004; 110: e82-e292
        • Hamm C.W.
        • Bertrand M.
        • Braunwald E.
        Acute coronary syndrome without ST elevation: implementation of new guidelines.
        Lancet. 2001; 358: 1533-1538
        • Petrina M.
        • Goodman S.G.
        • Eagle K.A.
        The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: current status in an era of revascularization and reperfusion.
        Am Heart J. 2006; 152: 11-18
        • Terkelsen C.J.
        • Lassen J.F.
        • Norgaard B.L.
        • et al.
        Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort.
        Eur Heart J. 2005; 26: 18-26
        • Montalescot G.
        • Dallongeville J.
        • Van Belle E.
        • et al.
        STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry).
        Eur Heart J. 2007; 28: 1409-1417
        • Morrow D.A.
        • Antman E.M.
        • Charlesworth A.
        • et al.
        TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy.
        Circulation. 2000; 102: 2031-2037
        • Antman E.M.
        • Cohen M.
        • Bernink P.J.
        • et al.
        The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making.
        JAMA. 2000; 284: 835-842
        • Mehta R.H.
        • O'Neill W.W.
        • Harjai K.J.
        • et al.
        Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions.
        Am J Cardiol. 2006; 97: 817-822
        • Eagle K.A.
        • Lim M.J.
        • Dabbous O.H.
        • et al.
        A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.
        JAMA. 2004; 291: 2727-2733
        • Chen K.Y.
        • Rha S.W.
        • Li Y.J.
        • et al.
        Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
        Circulation. 2009; 119: 3207-3214
        • Kang S.H.
        • Suh J.W.
        • Yoon C.H.
        • et al.
        Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).
        Am J Cardiol. 2012; 109: 787-793
        • Smith Jr., S.C.
        • Feldman T.E.
        • Hirshfeld Jr., J.W.
        • et al.
        ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).
        Circulation. 2006; 113: e166-e286
        • Chesebro J.H.
        • Knatterud G.
        • Roberts R.
        • et al.
        Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
        Circulation. 1987; 76: 142-154
        • Polonski L.
        • Gasior M.
        • Gierlotka M.
        • et al.
        A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?.
        Int J Cardiol. 2011; 152: 70-77
        • Garcia-Garcia C.
        • Subirana I.
        • Sala J.
        • et al.
        Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
        Am J Cardiol. 2011; 108: 1061-1067
        • Chan M.Y.
        • Sun J.L.
        • Newby L.K.
        • et al.
        Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.
        Circulation. 2009; 119: 3110-3117
        • Daida H.
        • Miyauchi K.
        • Ogawa H.
        • et al.
        Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry.
        Circ J. 2013; 77: 934-943
        • Steg P.G.
        • Goldberg R.J.
        • Gore J.M.
        • et al.
        Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).
        Am J Cardiol. 2002; 90: 358-363
        • Kim M.C.
        • Jeong M.H.
        • Ahn Y.
        • et al.
        What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
        Int J Cardiol. 2011; 153: 148-153
        • Vaccarino V.
        • Rathore S.S.
        • Wenger N.K.
        • et al.
        Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002.
        N Engl J Med. 2005; 353: 671-682
        • Guzman L.A.
        • Li S.
        • Wang T.Y.
        • et al.
        Differences in treatment patterns and outcomes between Hispanics and non-Hispanic Whites treated for ST-segment elevation myocardial infarction: results from the NCDR ACTION Registry-GWTG.
        J Am Coll Cardiol. 2012; 59: 630-631
        • Bi Y.
        • Gao R.
        • Patel A.
        • et al.
        Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
        Am Heart J. 2009; 157 ([e1]): 509-516
        • Fox K.A.
        • Goodman S.G.
        • Klein W.
        • et al.
        Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE).
        Eur Heart J. 2002; 23: 1177-1189
        • Mehran R.
        • Pocock S.J.
        • Stone G.W.
        • et al.
        Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
        Eur Heart J. 2009; 30: 1457-1466
        • Spencer F.A.
        • Moscucci M.
        • Granger C.B.
        • et al.
        Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?.
        Circulation. 2007; 116: 2793-2801
        • Lee J.H.
        • Park H.S.
        • Chae S.C.
        • et al.
        Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).
        Am J Cardiol. 2009; 104: 182-189
        • Song Y.B.
        • Hahn J.Y.
        • Kim J.H.
        • et al.
        Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention.
        Am J Cardiol. 2010; 106: 1397-1403